Tenet Healthcare THC Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Tenet Healthcare in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Tenet Healthcare’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tenet Healthcare's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tenet Healthcare's cash & equivalents?
- Tenet Healthcare (THC) reported cash & equivalents of $2.97B in Q1 2026.
- How has Tenet Healthcare's cash & equivalents changed year-over-year?
- Tenet Healthcare's cash & equivalents decreased by 1.1% year-over-year, from $3B to $2.97B.
- What is the long-term trend for Tenet Healthcare's cash & equivalents?
- Over 4 years (2021 to 2025), Tenet Healthcare's cash & equivalents has grown at a 5.1% compound annual growth rate (CAGR), from $2.36B to $2.88B.
- What does cash & equivalents mean?
- The total amount of cash and highly liquid investments the company has available for immediate use.
- How do you interpret cash & equivalents?
- An increase suggests improved liquidity and financial flexibility, while a decrease may indicate heavy capital expenditure or debt repayment.
- How does cash & equivalents compare across companies?
- Peers in the healthcare sector typically maintain cash balances proportional to their monthly operating expenses to ensure operational continuity.